Profil bibliographique

Frédérique Penault–Llorca

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées

7094Citations signalées

2Affiliations récentes

Institutions déclarées

Domaines associés

Cancer Immunotherapy and BiomarkersHER2/EGFR in Cancer ResearchCancer Genomics and DiagnosticsBreast Cancer Treatment StudiesLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2026 articleOpenAlex

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study

Julia Dixon‐Douglas, Damien Drubay, Roberto Salgado, Balazs Acs et autres

1 citationThe Lancet Oncology

Accès ouvert 2025 preprintOpenAlex

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Enora Laas, Anne‐Sophie Hamy, Thomas Bachelot, Paul Gougis et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2025 preprintOpenAlex

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the Ucbg- Unirad Trial

Enora Laas, Anne‐Sophie Hamy, Thomas Bachelot, Paul Gougis et autres

0 citationsSSRN Electronic Journal

Accès ouvert 2024 articleOpenAlex

Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics

Stanislas Quesada, Frédérique Penault–Llorca, Xavier Matías‐Guiu, Susana Banerjee et autres

19 citationsEuropean Journal of Cancer

Accès ouvert 2024 articleOpenAlex

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial

Angeline Ginzac, Ioana Molnar, Xavier Durando, Thibault De La Motte Rouge et autres

5 citationsBreast Cancer Research and Treatment

Accès ouvert 2023 articleOpenAlex

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study

Gwénaëlle Gravis, Patricia Marino, Daniel Olive, Frédérique Penault–Llorca et autres

20 citationsBMC Cancer

2023 articleOpenAlex

Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions

Julien Adam, Nolwenn Le Stang, Arnaud Uguen, Cécile Badoual et autres

13 citationsModern Pathology

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Tables 1-3 from Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions

Andréï Tchirkov, Eléonore Pierre-Eymard, J Dauplat, Inès Raoelfils et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)

Juliette Thariat, René‐Jean Bensadoun, Marie-Christine Étienne-Grimaldi, Dominique Grall et autres

0 citations

Accès ouvert 2021 articleOpenAlex

Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

Denis Horgan, Gennaro Ciliberto, PierFranco Conte, Giuseppe Curigliano et autres

1 citationCancers

Accès ouvert 2020 articleOpenAlex

Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology

Denis Horgan, Gennaro Ciliberto, PierFranco Conte, David Baldwin et autres

37 citationsBiomedicine Hub

Accès ouvert 2020 articleOpenAlex

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels et autres

211 citationsnpj Breast Cancer

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.